Literature DB >> 16224116

Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function.

Karel J van Erpecum1, David Q-H Wang, Antonio Moschetta, Domenico Ferri, Maria Svelto, Piero Portincasa, Jan-Jaap Hendrickx, Marguérite Schipper, Giuseppe Calamita.   

Abstract

C57L mice are susceptible and AKR mice are resistant to gallstone formation. We studied in male mice of both strains gallbladder histopathology, cholecystokinin-induced emptying, and concentrating function at 0, 14, 28, and 56 days on a lithogenic diet. Gallbladder wall thickness increased on the diet, with stromal granulocyte infiltration, progressive fibrosis, edema, and epithelial cell indentation, particularly in C57L. Strong basal cholecystokinin octapeptide-induced gallbladder emptying (70% of fasting volumes) occurred in both strains, but fasting gallbladder volumes were significantly larger in C57L (14.8 +/- 2.2 microl vs. 8.8 +/- 1.0 microl). On the diet, fasting volumes increased exclusively in C57L (28.6 +/- 2.9 microl on day 56), with progressively decreased emptying (27% of fasting volumes on day 56). Gallbladder emptying remained normal in AKR. Gallbladder concentrating function decreased on the lithogenic diet (especially in C57L), coinciding with decreased aquaporin-1 (AQP1) and AQP8 expression at the mRNA and protein levels. In additional experiments, similar downregulation of AQP1 and AQP8 mRNA expression occurred in farnesoid X receptor (FXR)-deficient mice after 1 week on the lithogenic diet, without any difference from corresponding wild-type mice. In conclusion, during murine lithogenesis, altered gallbladder histology is associated with impaired motility, reduced concentrating function, and decreased AQP1 and AQP8 expression, the latter without the involvement of the FXR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224116     DOI: 10.1194/jlr.M500180-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  27 in total

1.  Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.

Authors:  Brigitte Lavoie; Onesmo B Balemba; Cody Godfrey; Conall A Watson; Galya Vassileva; Carlos U Corvera; Mark T Nelson; Gary M Mawe
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

2.  Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

Authors:  B Lavoie; B Nausch; E A Zane; M R Leonard; O B Balemba; A C Bartoo; R Wilcox; M T Nelson; M C Carey; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

Review 3.  The inflammatory inception of gallbladder cancer.

Authors:  Jaime A Espinoza; Carolina Bizama; Patricia García; Catterina Ferreccio; Milind Javle; Juan F Miquel; Jill Koshiol; Juan C Roa
Journal:  Biochim Biophys Acta       Date:  2016-03-12

4.  Phosphorylation and subcellular localization of Na+/H+ exchanger isoform 3 (NHE3) are associated with altered gallbladder absorptive function after formation of cholesterol gallstones.

Authors:  Yongsheng Chen; Shuodong Wu; Yu Tian; Jing Kong
Journal:  J Physiol Biochem       Date:  2016-11-07       Impact factor: 4.158

Review 5.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

6.  Analysis of aquaporin expression in liver with a focus on hepatocytes.

Authors:  Françoise Gregoire; Valério Lucidi; Amal Zerrad-Saadi; Myrna Virreira; Nargis Bolaky; Valérie Delforge; Arnaud Lemmers; Vincent Donckier; Jacques Devière; Pieter Demetter; Jason Perret; Christine Delporte
Journal:  Histochem Cell Biol       Date:  2015-07-01       Impact factor: 4.304

7.  Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions.

Authors:  Jill Koshiol; Yu-Tang Gao; Amanda Corbel; Troy J Kemp; Ming-Chang Shen; Allan Hildesheim; Ann W Hsing; Asif Rashid; Bingsheng Wang; Ruth M Pfeiffer; Ligia A Pinto
Journal:  Cancer Epidemiol       Date:  2018-03-16       Impact factor: 2.984

8.  Endogenous elevation of plasma cholecystokinin does not prevent gallstones.

Authors:  Rafiq A Shahid; David Q-H Wang; Brian E Fee; Shannon J McCall; Joelle M-J Romac; Steven R Vigna; Rodger A Liddle
Journal:  Eur J Clin Invest       Date:  2015-03       Impact factor: 4.686

9.  Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones.

Authors:  Helen H Wang; Piero Portincasa; Nahum Mendez-Sanchez; Misael Uribe; David Q-H Wang
Journal:  Gastroenterology       Date:  2008-03-10       Impact factor: 22.682

10.  T-cell function is critical for murine cholesterol gallstone formation.

Authors:  Kirk J Maurer; Varada P Rao; Zhongming Ge; Arlin B Rogers; Trisha J Oura; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.